Quantcast

Latest radiopharmaceuticals Stories

2014-09-19 23:04:21

GIA announces the release of a comprehensive global report on Imaging Agents markets. Global market for Imaging Agents is projected to reach US$15.7 billion by 2020, driven by innovations in imaging technologies, rise in diagnostic examinations, growing geriatric population and rising use of advanced SPECT/CT and PET/CT scanners. San Jose, California (PRWEB) September 19, 2014 Follow us on LinkedIn – Imaging agents, an integral part of the medical imaging market, are engineered to...

2014-09-08 12:28:34

DUBLIN, Sept, 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Nuclear Medicine/Radiopharmaceuticals Global market - Forecast to 2020" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Nuclear medicine deals with the radioisotope applications in diagnosis and treatment of disease. Radiopharmaceuticals are drugs containing radionuclide's. Administration of radiopharmaceuticals facilitated to image bone, organs and the disease process...

2014-08-07 12:27:55

DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Medical imaging reagents play an important role in diagnostic, pharmaceuticals, biotechnology medical and life science industries. Medical imaging reagents allow clinicians and healthcare providers to determine...

2014-06-17 12:29:56

ALBANY, New York, June 17, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) - Global Industry Analysis, Size, Share, Growth,...

2014-06-09 08:29:41

Demonstrates Technology Suitable & Scalable for Multiple Brands of Cyclotrons ST. LOUIS, MO, June 9, 2014 /CNW/ - Today at the Society of Nuclear Medicine and Molecular Imaging's annual conference, a Canadian team with members from TRIUMF, the BC Cancer Agency, the Centre for Probe Development & Commercialization, and Lawson Health Research Institute announced that they have dramatically advanced technology for addressing the medical-isotope crisis. The key medical isotope,...

2014-06-05 23:12:50

GE Healthcare and Syntermed, Inc. will be exhibitors at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. AdreView Tools* will be featured by both companies as an advanced diagnostic tool to quantify and display SPECT 123I-mIBG) data sets, a new medical advance for diagnosis of heart failure. Atlanta, GA (PRWEB) June 05, 2014 Syntermed, Inc.’s software AdreView Tools, is now an option on GE Healthcare Xeleris 3.1 Processing & Review Workstation for SPECT...

2014-04-29 20:23:32

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Cardiovascular Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/world_market_cardiovascular_diagnostics_1.htmlThis report provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include:-- Electrocardiography including ECG testing, stress testing, Holter...

2014-04-29 12:32:37

SAINT-GENIS-POUILLY, France, April 29, 2014 /PRNewswire/ -- Advanced Accelerator Applications S.A. ("AAA" or "the Company"), an international specialist in Molecular Nuclear Medicine, today announced that Dr Kapil Dhingra has joined the Company Board of Directors as an Independent Non-Executive Director. Stefano Buono, Chief Executive Officer of AAA, commented: "Dr. Dhingra's guidance and perspective on clinical development, regulatory and commercial strategy will be...

2014-04-17 16:26:59

Lumiphore Inc., a pharmaceutical leader in bifunctional chelator design, is developing in vivo radio-diagnostic imaging and site-directed radio-therapeutics, using its proprietary bifunctional radionuclide metal-chelation technology; it has received a National Science Foundation Small Business Innovation Research (SBIR) Phase II Grant entitled "Novel macrocyclic chelating groups for use in targeted radioisotope diagnostic and companion diagnostic/therapeutic applications." BERKELEY,...

2014-04-09 16:25:48

MONTREAL, April 9, 2014 /PRNewswire/ - Jubilant DraxImage Inc., a Jubilant Life Sciences Company, is pleased to announce the appointment of Mr. Michael Rossi as Vice President, Sales and Business Operations, Jubilant DraxImage Inc., with effect from the 21(st) April 2014. Mr. Rossi has worked for GE Healthcare, Life Sciences since 2002, and currently holds the position of General Manager, Global SPECT Business. During his tenure with GE, he has led several commercial organizations...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related